心脏手术术后血管性休克的相关因素,以及使用精氨酸血管加压素作为抢救疗法对发病率和死亡率的影响。

IF 2.7 4区 医学 Q2 CRITICAL CARE MEDICINE
María Barrera Sánchez, Cristina Royo Villa, Pablo Ruiz de Gopegui Miguelena, Pablo Gutiérrez Ibañes, Andrés Carrillo López
{"title":"心脏手术术后血管性休克的相关因素,以及使用精氨酸血管加压素作为抢救疗法对发病率和死亡率的影响。","authors":"María Barrera Sánchez,&nbsp;Cristina Royo Villa,&nbsp;Pablo Ruiz de Gopegui Miguelena,&nbsp;Pablo Gutiérrez Ibañes,&nbsp;Andrés Carrillo López","doi":"10.1016/j.medin.2024.03.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Analizing associated factors with vasoplegic shock in the postoperative period of cardiac surgery. Analizing the influence of vasopressin as rescue therapy to first-line treatment with norepinephrine.</p></div><div><h3>Design</h3><p>Cohort, prospective and observational study.</p></div><div><h3>Setting</h3><p>Main hospital postoperative cardiac ICU.</p></div><div><h3>Patients</h3><p>Patients undergoing cardiac surgery with subsequent ICU admission from January 2021 to December 2022.</p></div><div><h3>Interventions</h3><p>Record of presurgical, perioperative and ICU discharge clinical variables.</p></div><div><h3>Main variables of interest</h3><p>Chronic treatment, presence of vasoplegic shock, need for vasopressin, cardiopulmonary bypass time, mortality.</p></div><div><h3>Results</h3><p>773 patients met the inclusion criteria. The average age was 67.3, with predominance of males (65.7%). Post-CPB vasoplegia was documented in 94 patients (12.2%). In multivariate analysis, vasoplegia was associated with age, female sex, presurgical creatinine levels, cardiopulmonary bypass time, lactate level upon admission to the ICU, and need for prothrombin complex transfusion. Of the patients who developed vasoplegia, 18 (19%) required rescue vasopressin, associated with pre-surgical intake of ACEIs/ARBs, worse EuroScore score and longer cardiopulmonary bypass time. Refractory vasoplegia with vasopressin requirement was associated with increased morbidity and mortality.</p></div><div><h3>Conclusions</h3><p>Postcardiopulmonary bypass vasoplegia is associated with increased mortality and morbidity. Shortening cardiopulmonary bypass times and minimizing products blood transfusion could reduce its development. Removing ACEIs and ARBs prior to surgery could reduce the incidence of refractory vasoplegia requiring rescue with vasopressin. The first-line treatment is norepinephrine and rescue treatment with vasopressin is a good choice in refractory situations. The first-line treatment of this syndrome is norepinephrine, although rescue with vasopressin is a good complement in refractory situations.</p></div>","PeriodicalId":49268,"journal":{"name":"Medicina Intensiva","volume":"48 7","pages":"Pages 392-402"},"PeriodicalIF":2.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Factores asociados a shock vasopléjico en el postoperatorio de cirugía cardiaca e influencia en la morbimortalidad del uso de arginina vasopresina como terapia de rescate\",\"authors\":\"María Barrera Sánchez,&nbsp;Cristina Royo Villa,&nbsp;Pablo Ruiz de Gopegui Miguelena,&nbsp;Pablo Gutiérrez Ibañes,&nbsp;Andrés Carrillo López\",\"doi\":\"10.1016/j.medin.2024.03.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>Analizing associated factors with vasoplegic shock in the postoperative period of cardiac surgery. Analizing the influence of vasopressin as rescue therapy to first-line treatment with norepinephrine.</p></div><div><h3>Design</h3><p>Cohort, prospective and observational study.</p></div><div><h3>Setting</h3><p>Main hospital postoperative cardiac ICU.</p></div><div><h3>Patients</h3><p>Patients undergoing cardiac surgery with subsequent ICU admission from January 2021 to December 2022.</p></div><div><h3>Interventions</h3><p>Record of presurgical, perioperative and ICU discharge clinical variables.</p></div><div><h3>Main variables of interest</h3><p>Chronic treatment, presence of vasoplegic shock, need for vasopressin, cardiopulmonary bypass time, mortality.</p></div><div><h3>Results</h3><p>773 patients met the inclusion criteria. The average age was 67.3, with predominance of males (65.7%). Post-CPB vasoplegia was documented in 94 patients (12.2%). In multivariate analysis, vasoplegia was associated with age, female sex, presurgical creatinine levels, cardiopulmonary bypass time, lactate level upon admission to the ICU, and need for prothrombin complex transfusion. Of the patients who developed vasoplegia, 18 (19%) required rescue vasopressin, associated with pre-surgical intake of ACEIs/ARBs, worse EuroScore score and longer cardiopulmonary bypass time. Refractory vasoplegia with vasopressin requirement was associated with increased morbidity and mortality.</p></div><div><h3>Conclusions</h3><p>Postcardiopulmonary bypass vasoplegia is associated with increased mortality and morbidity. Shortening cardiopulmonary bypass times and minimizing products blood transfusion could reduce its development. Removing ACEIs and ARBs prior to surgery could reduce the incidence of refractory vasoplegia requiring rescue with vasopressin. The first-line treatment is norepinephrine and rescue treatment with vasopressin is a good choice in refractory situations. The first-line treatment of this syndrome is norepinephrine, although rescue with vasopressin is a good complement in refractory situations.</p></div>\",\"PeriodicalId\":49268,\"journal\":{\"name\":\"Medicina Intensiva\",\"volume\":\"48 7\",\"pages\":\"Pages 392-402\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina Intensiva\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0210569124000822\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Intensiva","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210569124000822","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

目的 分析心脏手术术后血管性休克的相关因素。分析血管加压素作为去甲肾上腺素一线治疗的抢救疗法的影响.设计队列、前瞻性和观察性研究.设置主要医院术后心脏重症监护室.患者2021年1月至2022年12月期间接受心脏手术并随后入住重症监护室的患者.干预措施记录手术前、围手术期和 ICU 出院时的临床变量。主要关注变量慢性治疗、是否出现血管性休克、是否需要使用血管加压素、心肺旁路时间、死亡率。平均年龄为 67.3 岁,男性居多(65.7%)。有 94 名患者(12.2%)在 CPB 后出现血管瘫痪。在多变量分析中,血管痉挛与年龄、女性性别、手术前肌酐水平、心肺旁路时间、进入重症监护室时的乳酸水平以及凝血酶原复合物输血需求有关。在出现血管痉挛的患者中,有 18 人(19%)需要使用血管加压素,这与手术前服用 ACEIs/ARB、EuroScore 评分较差和心肺旁路时间较长有关。结论 心肺旁路术后血管痉挛与死亡率和发病率增加有关。缩短心肺旁路时间和尽量减少产品输血可减少血管痉挛的发生。手术前停用 ACEIs 和 ARBs 可减少需要使用血管加压素抢救的难治性血管痉挛的发生率。去甲肾上腺素是一线治疗药物,在难治性情况下,使用血管加压素进行抢救是一个不错的选择。去甲肾上腺素是这种综合征的一线治疗药物,但在难治性情况下,使用血管加压素进行抢救是一种很好的补充。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Factores asociados a shock vasopléjico en el postoperatorio de cirugía cardiaca e influencia en la morbimortalidad del uso de arginina vasopresina como terapia de rescate

Objectives

Analizing associated factors with vasoplegic shock in the postoperative period of cardiac surgery. Analizing the influence of vasopressin as rescue therapy to first-line treatment with norepinephrine.

Design

Cohort, prospective and observational study.

Setting

Main hospital postoperative cardiac ICU.

Patients

Patients undergoing cardiac surgery with subsequent ICU admission from January 2021 to December 2022.

Interventions

Record of presurgical, perioperative and ICU discharge clinical variables.

Main variables of interest

Chronic treatment, presence of vasoplegic shock, need for vasopressin, cardiopulmonary bypass time, mortality.

Results

773 patients met the inclusion criteria. The average age was 67.3, with predominance of males (65.7%). Post-CPB vasoplegia was documented in 94 patients (12.2%). In multivariate analysis, vasoplegia was associated with age, female sex, presurgical creatinine levels, cardiopulmonary bypass time, lactate level upon admission to the ICU, and need for prothrombin complex transfusion. Of the patients who developed vasoplegia, 18 (19%) required rescue vasopressin, associated with pre-surgical intake of ACEIs/ARBs, worse EuroScore score and longer cardiopulmonary bypass time. Refractory vasoplegia with vasopressin requirement was associated with increased morbidity and mortality.

Conclusions

Postcardiopulmonary bypass vasoplegia is associated with increased mortality and morbidity. Shortening cardiopulmonary bypass times and minimizing products blood transfusion could reduce its development. Removing ACEIs and ARBs prior to surgery could reduce the incidence of refractory vasoplegia requiring rescue with vasopressin. The first-line treatment is norepinephrine and rescue treatment with vasopressin is a good choice in refractory situations. The first-line treatment of this syndrome is norepinephrine, although rescue with vasopressin is a good complement in refractory situations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicina Intensiva
Medicina Intensiva CRITICAL CARE MEDICINE-
CiteScore
2.70
自引率
20.00%
发文量
146
审稿时长
33 days
期刊介绍: Medicina Intensiva is the journal of the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC) and of Pan American and Iberian Federation of Societies of Intensive and Critical Care Medicine. Medicina Intensiva has become the reference publication in Spanish in its field. The journal mainly publishes Original Articles, Reviews, Clinical Notes, Consensus Documents, Images, and other information relevant to the specialty. All works go through a rigorous selection process. The journal accepts submissions of articles in English and in Spanish languages. The journal follows the publication requirements of the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信